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Abbreviations
Boc butoxycarbonyl, CBz benzyloxycarbonyl, DCCI dicyclohexylcarbodiimide, DMF N,N-
dimethylformamide, DMSO dimethyl sulfoxide, HOBt hydroxybenzotriazole, TEA triethylamine,
TFA trifluoroacetic acid, –R– reduced peptide bond.
Inhibitor synthesis
The inhibitors were made using manual solid-phase Boc synthetic techniques and had sequences
based on those commonly occurring at chymosin and Mucor Pusillus pepsin cleavage sites in the
insulin β-chain.
H2N-His-Pro-His-Leu-Ser-Phe–R–Met-Ala-Tyr-COOH ... (DB1)
H2N-His-Pro-His-Leu-Ser-Phe–R–Met-Ala-Ile-COOH ... (DB2)
H2N-His-Pro-His-Leu-Ser-Ile–R–Met-Ala-Ile-COOH ... (DB3)
H2N-His-Pro-His-Leu-Ser-Phe–R–Met-Ala-His-COOH ... (DB4/5)
H2N-His-Ser-Leu-Phe-His-Phe–R–Phe-Thr-Pro-COOH ... (DB6)
Synthetic Strategy
The first three amino acids at the C-terminal end of each inhibitor were linked to the resin
sequentially and a small amount of the resin was removed for analysis. During this time the
compound required to form the reduced bond with the free amino group was synthesised. This
compound was always a Boc-protected aldehyde of the next amino acid in the sequence which
was coupled to the free amino end of the resin-linked tripeptide by reductive amination. The
resin would then be reloaded and the synthesis continued until the remaining five other amino
acids were attached. After this each peptide was cleaved from the resin using anhydrous hydrogen
fluoride, analysed as before and then purified by HPLC chromatography.
The imidazole ring of histidine was protected with Boc, serine and threonine hydroxyls with
benzyl ethers and the tyrosine hydroxyl with the Cbz group.
Synthesis of the Aldehyde
Two Boc-protected aldehydes were synthesised, Boc-Leu-CHO and Boc-Phe-CHO. A summary
of the steps which are detailed below is shown in Figure 1.
Preparation of Boc-Phe-COOMe
An ethereal solution of diazomethane was prepared by adding 20g of N-methyl-N-nitrosourea
to 60ml of a 40% KOH solution under 240ml of ether. The diazomethane was distilled using dry
ice/ethanol as a cooling medium. The resulting solution was poured onto an ethereal solution of
Boc-Phe-COOH. The un-recrystallised residue Boc-Phe-COOMe was used in the next stage of the
synthesis.
Preparation of Boc-Phe-CH2-OH
The un-recrystallised methyl ester was dissolved in 350ml of dioxane and cooled to 10◦C where-
upon 20g of sodium borohydride (NaBH4) was added and the temperature maintained at 10
◦C
for 1 hour whilst at the same time adding a solution of 25ml acetic acid in 100ml dioxane. This
mixture was then refluxed for 11
2
hours, after which 100ml of methanol was added. The solvent
was removed by rotary evaporation and the residue dissolved in 250ml of saturated sodium bicar-
bonate. This solution was extracted three times with 150ml portions of ethyl acetate and dried
over sodium sulphate. The residue remaining after rotary evaporation was redissolved in ether and
crystallised from a mixture of butyl methyl ether and hexane to give the alcohol Boc-Phe-CH2-OH.
Preparation of Boc-Phe-CHO
A four-necked flask was set up with a stirrer, spirit thermometer and two dropping funnels. 1ml
of oxalyl chloride ((COCl)2) was dissolved in 25ml of CH2Cl2 and cooled using a dry ice/ethanol
mix to -50◦/-60◦. From one funnel, 1.7ml of dimethylsulphoxide ((CH3)2SO) in 5ml of CH2Cl2 was
added and after two minutes a solution of 2.51g of Boc-Phe-CH2-OH in 20ml of CH2Cl2 was added
over five minutes from the second dropping funnel. After a further 15 minutes, 7ml of TEA was
added and the resulting solution stirred for five minutes. The reaction mixture was then allowed to
reach room temperature and the water layer extracted with 50ml of CH2Cl2. The organic layers
were then combined and quickly extracted with saturated NaCl and dried over MgSO4. After
rotary evaporation a yellow oil was obtained which was immediately stored in the cold to prevent
further degradation. This raw aldehyde undoubtedly contained some impurities.
Figure 1: Preparation of Boc-Phe-Aldehyde
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Peptide Synthesis Protocol
The synthesis of each peptide inhibitor consisted of the following stages.
1. Attachment of first amino acid residue to the resin
2. Attachment of the 3 amino acid residues up to the reduced bond
3. Formation of reduced bond
4. Attachment of remaining amino acid residues
5. Cleavage of peptide inhibitor
6. Purification and characterisation of inhibitor
The sequential attachment of the residues consisted of three stages, deprotection, neutralisation
and coupling, as shown in Figure 2.
The attachment of the initial amino acid to the resin was performed using DMF and KI at
60◦C. The resin was then loaded into the reaction vessel and the protecting Boc group removed by
washing the resin twice with a 50% solution of trifluoroacetic acid (TFA) in CH2Cl2 and stirring
for 30 minutes. The excess acid was removed with washes of CH2Cl2 and a solution of 30% dioxane
in CH2Cl2. Neutralisation of the product was achieved using TEA as a 10% solution in CH2Cl2
to form the tert-ammonium salt, which was washed away prior to attachment of the next amino
acid. A DCCI/HOBt mix was used as the coupling agent.
Figure 2: Peptide Synthesis Protocol
First residue attachment
?
50% TFA/CH2Cl2 2 x 2 minutes
Then 30 minutes
?
CH2Cl2 3 x 1 minute
30% Dioxane/CH2Cl2 3 x 1 minute
CH2Cl2 3 x 1 minute
10% Et3N/CH2Cl2 2 minutes
CH2Cl2 3 x 1 minute
10% Et3N/CH2Cl2 2 minutes
CH2Cl2 6 x 1 minute
3 eqv. HOBt esters of amino acids
> 30 min - (check with Kaiser Test)
?
?
50% EtOH/CH2Cl2 3 x 1 minute
CH2Cl2 3 x 1 minute
-
Peptide Cleavage
Formation of the reduced bond
The reduced peptide bond analogue was formed by reductive amination of the Boc-Phe-Aldehyde
by the resin linked peptide. The reaction proceeds via an imine intermediate as shown in Figure 3.
The reducing agent used, sodium cyanoborohydride, reduces the imine group more rapidly than
the carbonyl.
The raw aldehyde was dissolved in CH2Cl2 as was the peptide resin, and to this mixture a 3eqv.
excess of sodium cyanoborohydride (NaBH3CN) in acetic acid buffered-DMF was added, followed
by shaking overnight. The resulting reaction mix was then treated according to the following
protocol :
?
DMF x 2
CH3OH x 2
CH3OH/H2O x 2
CH3OH x 2
DMF x 2
x 2
?
tert-butylmethyl ether x 2
The reaction was repeated with more aldehyde, after which the final six residues were added
in the conventional way. Anhydrous hydrogen fluoride was used to cleave the peptide from the
resin in anisole for one hour on ice and excess HF was then flushed away with nitrogen. Each
peptide was then recovered from the resin and any anisole degradation products by trituration
with ether. Peptides were purified by reverse phase HPLC on a Sepharon C18 column and were
characterised by liquid secondary ion mass spectrometry (LSIMS) using a ZAB-EQ instrument
from V6 Analytical Ltd, Manchester (see following mass-spectra). Formation of the reduced bond
is expected to lead to some racemisation at the P1 residue. However when the DB5 and DB6
complexes were solved, the L configuration was confirmed.
Figure 3: Reductive Amination
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relation to crystal packing of aspartic proteinases.’
Table 5: The contacts made by the sulphate groups in type IV native endothiapepsin. Note that
the residues are numbered according to the scheme of Blundell et al., (1990) in which insertions
relative to porcine pepsin are indicated by suffixes by A, B, C, etc.
Residue Sulphate Atom VDW contacts Hydrogen Bonds
Intramolecular Contacts
SO4 1 (19vdw 4hb)
Ser 108 O1 1 0
W205 O1 1 0
Ser 108 O2 2 0
W204 O2 1 1
W205 O2 1 1
Ser 108 O3 3 0
Ser 109 O3 2 0
Ser 108 O4 3 0
Ser 109 O4 4 2
W74 O4 1 0
SO4 2 (15vdw 7hb)
Ser 240 O1 4 1
Ser 241 O1 1 1
Ser 240 O2 1 1
Ser 242 O2 4 2
Lys 238A O4 2 1
Ser 240 O4 3 1
SO4 3 (19vdw 5hb)
Tyr 175 O1 3 1
Gly 177 O1 1 0
Ser 178 O1 2 0
W238 O1 1 0
Ser 178 O2 3 0
Ile 179 O2 5 1
Tyr 175 O3 1 1
W211 O3 1 1
W238 O3 1 1
Ser 178 O4 1 0
Intermolecular Contacts
SO4 1 · · · (−x, y + 1/2, 1− z)
Ser 236 O2 1 1
Ser 236 O3 1 1
SO4 1 · · · (x, y, 1 + z)
Thr 318 O1 1 0
Thr 318 O3 2 0
Thr 319 O1 1 1
Thr 319 O4 2 1
SO4 2 · · · (x, y − 1/2, 1− z)
Ser 132 O1 1 1
Ser 132 O3 2 1
Pro 133 O3 1 0
SO4 3 · · · (1− x, y − 1/2,−z)
Lys 64 O1 1 1
Table 6: The lattice contacts in type IV endothiapepsin crystals. Note that the residues are
numbered according to the scheme of Blundell et al., (1990) in which insertions relative to porcine
pepsin are indicated by suffixes by A, B, C, etc.
Contactants H-Bonding Residue Biso Type IV Biso
Molecule at (1 + x, y, z)
Ser 1 · · · Thr 226 10.8 (2.6) · · · 15.2 (2.9) 12.6 (3.8) · · · 7.3 (2.2)
Gln 19 · · · Ala 295 7.0 (1.5) · · · 17.2 (3.7) 10.9 (9.6) · · · 12.5 (3.7)
Ala 24 · · · Gly 296 11.1 (2.1) · · · 21.1 (5.3) 10.6 (3.6) · · · 17.4 (4.0)
Molecule at (x, y, 1 + z)
Ala 47 · · · Ala 144 O → O
Ser 48 · · · Lys 143
Glu 49 · · · Thr 318 O2 → Oγ1
Asp 51 · · · Asp 147 Oδ2 → O
Asp 51 · · · Ser 148 Oδ1 or Oδ2 → Oγ
Asp 51 · · · Pro 149
Gly 52 · · · Asp 147 N → O
Ser 109 · · · Ala 317
Ser 109 · · · Thr 318 Oγ → N 11.6 (6.3) · · · 19.0 (3.8) 22.0 (7.0) · · · 32.8 (9.4)
Ser 109 · · · Thr 319 Oγ → N 11.6 (6.3) · · · 13.9 (5.3) 22.0 (7.0) · · · 19.9 (6.2)
Glu 113 · · · Asn 315 O1 → Nδ2 20.6 (5.4) · · · 11.4 (4.0) 27.5 (7.0) · · · 16.5 (5.6)
Glu 113 · · · Ala 317 20.6 (5.4) · · · 14.9 (5.5) 27.5 (7.0) · · · 17.8 (6.6)
Ser 279 · · · Ser 178 Oγ → Oγ
Thr 280 · · · Gly 177
Thr 280 · · · Ser 178 N → Oγ
Molecule at (−x, y + 1/2,−z)
Phe 125 · · · Ser 201
Ser 126 · · · Ser 201 N → O
Ser 126 · · · Thr 203
Thr 127 · · · Ser 201 N → O
Thr 127 · · · Gly 202 N → O
Pro 133 · · · Ser 204A
Thr 134 · · · Phe 203A
Thr 134 · · · Ser 204A Oγ1 → N
Gln 134A · · · Thr 203
Gln 134A · · · Phe 203A N → O & N2 or O1 → N
Gln 135 · · · Thr 203
Lys 136 · · · Thr 203
Thr 185 · · · Ser 201
Table 6: continued.
Contactants H-Bonding Residue Biso Type I Biso
Molecule at (1− x, y + 1/2,−z)
Lys 64 · · · Gly 177 Nζ → O
Molecule at (−x, y + 1/2, 1− z)
Thr 70 · · · Lys 238A Oγ → Nζ
Ser 72 · · · Gly 237 Oγ → O
Ser 74 · · · Pro 249
Ser 80 · · · Ser 236 Oγ → Oγ
Ser 80 · · · Gly 237 O → Oγ
Ser 80A · · · Ser 236
Ser 81 · · · Ser 236 N → O
Ser 81 · · · Gly 237
Ser 81 · · · Ala 238 Oγ → O
Lys 106 · · · Trp 232 Nζ → O
Lys 106 · · · Ala 233
Lys 106 · · · Val 235 Nζ → O
Lys 106 · · · Ser 236
Lys 106 · · · Ala 238 Nζ → O
Val 107 · · · Ser 236
Ser 108 · · · Ser 236 N → Oγ
Ser 132 · · · Lys 238A
Molecule at (1− x, y + 1/2, 1− z)
Ser 59 · · · His 158
Thr 62 · · · Pro 277
Thr 62 · · · Thr 280
Thr 62 · · · Gly 281 O → N
Thr 62 · · · Ser 282 Oγ1 → O or Cβ → O
Thr 63 · · · Thr 280
Thr 63 · · · Gly 281
Lys 64 · · · Thr 280
Table 7: The lattice contacts in type I endothiapepsin crystals.
Residues H-Bonding Residue Biso Type I Biso
Molecule at (x, y, 1 + z)
Tyr 175 · · · Gly 281
Ser 178 · · · Gly 281 Oγ → O
Ile 179 · · · Thr 280
Ile 179 · · · Gly 281 N → O
Ile 179 · · · Ser 282 O → N
Tyr 181 · · · Ser 279
Tyr 181 · · · Thr 280 OH → O
Molecule at (1 + x, y, 1 + z)
Leu 66 · · · Ser 251
Ser 67 · · · Cys 250
Ser 67 · · · Ser 251 O → Oγ
Ser 67 · · · Ser 282A
Gly 68 · · · Ser 282A
Pro 133 · · · Pro 249
Thr 134 · · · Ser 251 Oγ1 → Oγ
Thr 134 · · · Ala 252 Oγ1 → N
Molecule at (1− x, y + 1/2,−z)
Thr 3 · · · Ala 225
Pro 17 · · · Ser 229
Gln 19 · · · Ser 229 O1 → Oγ
Gln 19 · · · Ala 233
Ala 24 · · · Gln 234 O → N1
Thr 26 · · · Ala 230
Thr 26 · · · Ala 233
Asn 28 · · · Lys 204 Oδ1 → N
Asn 28 · · · Thr 226
Thr 54 · · · Lys 204
Pro 162 · · · Ala 295
